News
Reproducible translation of transcriptomics data has been hampered by the ubiquitous presence of batch effects. Statistical methods for managing batch effects were initially developed in the setting ...
IGI Therapeutics SA, has signed with Abbvie Inc. a global licensing partnership for trispecific antibody ISB-2001 worth $1.925 billion plus royalties. ISB-2001, which targets BCMA, CD38 and CD3, is in ...
Novartis has inked a deal with Sironax that gives the pharma the exclusive option to acquire the biotech’s blood-brain ...
Sironax, a clinical-stage biotech company dedicated to the discovery and development of transformational therapies for age-related diseases, today announced a strategic agreement with Novartis under ...
Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global ...
Baseus Unveils Revolutionary EnerCore Charging Solutions, Eliminating Cable Clutter Without CompromiseDisclaimer The content, including but not limited to any articles, news, quotes, information, data ...
JuCoin Launches Ostra IEO, Southeast Asia's First Tokenized EV Infrastructure ProjectDisclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ...
CAMBRIDGE, MA, USA I June 30, 2025 I XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine ...
Basel, June 25, 2025 - Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. ("Regulus"). With the completion of the acquisition, shares of ...
PHILADELPHIA, PA and MALVERN, PA, USA I June 23, 2025 I Carisma Therapeutics Inc. (Nasdaq: CARM) (Carisma) and OrthoCellix, Inc. (OrthoCellix), a wholly-owned subsidiary of Ocugen, Inc. (Nasdaq: OCGN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results